Your browser doesn't support javascript.
loading
A miRNA signature predicts benefit from addition of hypoxia-modifying therapy to radiation treatment in invasive bladder cancer.
Khan, Mairah T; Irlam-Jones, Joely J; Pereira, Ronnie Rodrigues; Lane, Brian; Valentine, Helen R; Aragaki, Kai; Dyrskjøt, Lars; McConkey, David J; Hoskin, Peter J; Choudhury, Ananya; West, Catharine M L.
Afiliação
  • Khan MT; Translational Radiobiology Group, Division of Cancer Sciences, University of Manchester, Manchester Academic Health Science Centre, Christie NHS Foundation Trust Hospital, Manchester, UK.
  • Irlam-Jones JJ; Translational Radiobiology Group, Division of Cancer Sciences, University of Manchester, Manchester Academic Health Science Centre, Christie NHS Foundation Trust Hospital, Manchester, UK.
  • Pereira RR; Translational Oncogenomics, Cancer Research UK Manchester Institute, Oglesby Cancer Research Building, University of Manchester, Manchester, UK.
  • Lane B; Translational Radiobiology Group, Division of Cancer Sciences, University of Manchester, Manchester Academic Health Science Centre, Christie NHS Foundation Trust Hospital, Manchester, UK.
  • Valentine HR; Translational Radiobiology Group, Division of Cancer Sciences, University of Manchester, Manchester Academic Health Science Centre, Christie NHS Foundation Trust Hospital, Manchester, UK.
  • Aragaki K; Greenberg Bladder Cancer Institute, Johns Hopkins University, Baltimore, MD, USA.
  • Dyrskjøt L; Department of Molecular Medicine, Aarhus University Hospital, Aarhus, Denmark.
  • McConkey DJ; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.
  • Hoskin PJ; Greenberg Bladder Cancer Institute, Johns Hopkins University, Baltimore, MD, USA.
  • Choudhury A; Translational Radiobiology Group, Division of Cancer Sciences, University of Manchester, Manchester Academic Health Science Centre, Christie NHS Foundation Trust Hospital, Manchester, UK.
  • West CML; Translational Radiobiology Group, Division of Cancer Sciences, University of Manchester, Manchester Academic Health Science Centre, Christie NHS Foundation Trust Hospital, Manchester, UK.
Br J Cancer ; 125(1): 85-93, 2021 07.
Article em En | MEDLINE | ID: mdl-33846523
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Oxigênio / Neoplasias da Bexiga Urinária / Dióxido de Carbono / Niacinamida / MicroRNAs Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Oxigênio / Neoplasias da Bexiga Urinária / Dióxido de Carbono / Niacinamida / MicroRNAs Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article